Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection

Ruoyu Zhang,Yunfei Tan,Mei Liu,Liming Wang
DOI: https://doi.org/10.1097/meg.0000000000002856
2024-10-31
European Journal of Gastroenterology & Hepatology
Abstract:Intrahepatic cholangiocarcinoma (ICC) is the most common type of primary liver cancer, second only to hepatocellular carcinoma [ 1 , 2 ]. The mortality rate of ICC is about 1–2/100 000 in most countries and is on the rise globally [ 3 ]. ICC may be related to chronic biliary inflammation caused by clonorchiasis, choledocholithiasis, cholelithiasis, or primary sclerosing cholangitis [ 4 , 5 ]. Besides, the research found a positive association of hepatitis B virus, hepatitis C virus, and Epstein–Barr virus infection in ICC with obvious genetic and clinicopathological characteristics [ 6 , 7 ]. Smoking, drinking, and nonalcoholic fatty liver disease are correlated with ICC [ 6 ]. ICC is a highly lethal carcinoma originating from bile duct epithelial cells of the intrahepatic biliary tree. Most ICCs are characterized by tubular or acinar adenocarcinoma with rich tumor stroma [ 8 ]. Clinically, ICC can be divided into intraductal growth, periductal infiltrating, mass forming, and the mixed patterns above [ 9 ]. Pathological subtypes of ICC are mainly divided into large-duct type and small-duct type [ 10 ]. The early symptoms of ICC are not obvious, and numerous patients are already in the advanced stage of ICC when diagnosed, which seriously affects the treatment. Hepatectomy is the main treatment for ICC [ 11 ], but only a small number of patients (15%) are suitable for surgery [ 12 ]. In addition, the 5-year survival rate after surgical resection is only 22–44% [ 5 ]. Although progress has been made to develop new treatment strategies, the prognosis of ICC is very poor [ 5 ]. The median survival time is only 7.0 months, and the 5-year overall survival (OS) rate is only 7.90% [ 13 ]. Postoperative recurrence and metastasis are the main causes of death in patients [ 14 ].
gastroenterology & hepatology
What problem does this paper attempt to address?